The ability of concentrated antibody against the 78-or 40-kilodalton (kDa) 
ability against H. somnus pneumonia following active immunization.
Haemophilus somnus is a bovine mucosal and systemic bacterial pathogen which can also colonize the nasal and genital mucosa asymptomatically (10, (20) (21) (22) . Respiratory disease (1, 22) , reproductive failure (6, 22) , and thromboembolic meningoencephalitis (22, 41) are the predominant diseases associated with H. somnus infections. Losses caused by H. somnus pneumonia occur worldwide, with reports of disease from North America (5), Europe (35, 39, 44) , and Australia (29) . Pneumonia is one of the most important health problems facing the American cattle industry, with annual losses in excess of $500 million (34) , and the contribution of H. somnus to these losses is only beginning to be recognized (49) . In a case-control study in southern Ontario, H. somnus was isolated from 28.8% of cases of bovine pneumonia in animals under 1 year of age (S. C. Groom and P. B. Little, Conf. Res. Workers Anim. Dis., abstr. 240, p. 44, 1985) . In the midwestern United States, Andrews et al. (1) found that H. somnus isolations from cattle with pneumonic lungs were far more frequent than isolations from cattle with thromboembolic meningoencephalitis (162 isolates compared with 21 isolates, respectively, over a 5-year period). This allowed them to conclude that the role of H. somnus as an etiologic agent of pneumonia in the United States may be underestimated and often unrecognized. Ad (18, 32) . Antigenic competition is thought to be one possible explanation for the low level of protection induced by many killed vaccines (3) . Subunit vaccines (2, 23) or monoclonal antibodies (38) have been shown to protect against bacteria which cause pneumonia in other species, so we directed our investigation of H. somnus pneumonia toward prophylaxis with purified antigens that may be important in eliciting protective immunity. Initially, we produced acute H.somnus pneumonia in calves and characterized changes both qualitatively and quantitatively (16) . Subsequently, we demonstrated passive protection with serum from calves that had recovered from H. somnus pneumonia. This was done by preincubation of bacteria with convalescent-phase serum prior to intrabronchial inoculation into recipient calves (15) . Analysis of the specificity of this protective convalescent-phase serum by sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis (PAGE) of H. somnus outer membrane-enriched fractions or whole bacteria followed by Western blotting revealed that the predominant response was directed against H. somnus outer membrane proteins (OMPs) with apparent molecular masses of 78 and 40 kilodaltons (kDa) (15) . These antigens were shown to be surface exposed and accessible to antibody (15) and to be conserved among a wide range of H. somnus isolates from animals with different diseases and from different geographic locations (7; S. A. Kania, M. S. thesis, Washington State University, Pullman, 1987). They were thus considered to be good candidate antigens for a subunit vaccine against H. somnus pneumonia. Furthermore, Stephens et al. (41) have shown that outer membrane complexes protect against H. somnus-induced thromboembolic meningoencephalitis. These data provide a basis for the hypothesis that antibodies against the 78-kDa OMP or the 40-kDa OMP (or both) of H. somnus protect against H. somnus pneumonia.
We report here that preincubation of bacteria with an immunoglobulin fraction containing immunoglobulin G1 (IgGl) and IgG2 antibody against the 40-kDa OMP passively protects calves against H. somnus pneumonia, while an immunoglobulin fraction containing IgGl antibody against the 78-kDa OMP does not passively protect calves against H. somnus pneumonia.
MATERIALS AND METHODS
Bacteria. H. somnus 2336 was the only pathogen isolated at the Washington Animal Disease Diagnostic Laboratory (Pullman, Wash.) from the lungs of a 5-week-old vealer calf during an outbreak of H. somnus pneumonia. Isolates from the primary culture were stored at -70°C in 40% phosphatebuffered saline (PBS)-60% glycerol. This isolate was thawed and passaged once in a calf, and the calf-passaged isolate of strain 2336 was stored at -70°C for use in this study. For enzyme-linked immunosorbent assays (ELISAs) and SDS-PAGE, H. somnus was grown overnight at 37°C in 10% CO2 on Columbia blood agar plates containing 10% bovine blood. These cultures were then used to seed brain heart infusion broth containing 0.1% Tris base and 0.001% thiamine monophosphate (24) . Broth cultures were grown to the late log phase (5 to 6 h) in a shaking water bath at 37°C, yielding approximately 109 bacteria per ml. For passive protection experiments, bacteria were subcultured once and grown on Columbia blood agar plates containing 10% fetal bovine serum (HyClone Laboratories, Logan, Utah) for 18 h.
Animals. Holstein bull calves were purchased from dairies in which there was no evidence of H. somnus disease. While under study, the calves were housed indoors on rubber mats and were fed grain and alfalfa hay or pellets.
Sera. (i) Convalescent-phase serum. Convalescent-phase serum was prepared as described previously (15) . Briefly, a 12-week-old male Holstein calf (E7) was inoculated intrabronchially with 107 CFU of H. somnus. Preimmune serum was collected before inoculation, and convalescent-phase serum was collected 6 weeks after inoculation. Clinical signs of mild pneumonia developed, and H. somnus was recovered by bronchoalveolar lavage on weeks 1, 2, 3, 4, and 5 after inoculation. At necropsy at 6 weeks after inoculation, there was focal, mild, resolving pneumonia at the site of inoculation; and there were marked elevations of IgGl and IgG2 serum antibodies specific for H. somnus, as determined by ELISA (15) .
(ii) Antiserum against the 78-kDa OMP. Antiserum against the 78-kDa OMP was prepared as described by Kania (M.S. thesis). In brief, H. somnus outer membrane-enriched fractions were obtained by N-lauroyl-sarcosine (Sigma Chemical Co., St. Louis, Mo.) solubilization of cytoplasmic membrane components as described previously (15) , except that bacteria were disrupted by using a French press at a pressure of of H. somnus LPS that was purified by hot phenol-water extraction as described previously (15) . If mean backgrounds in the LPS ELISAs were higher than an OD of 0.1, endpoints were taken at twice the mean background level. SDS-PAGE. Discontinuous SDS-PAGE was done by using 1.5-mm-thick slab gels with stacking and gradient gels of 5% and 7.5 to 17.5% (wt/vol) polyacrylamide, respectively, unless indicated otherwise. Whole bacteria (-3 x 109/ml) were solubilized by boiling them for 5 min in SDS-gel sample buffer (28) , and approximately 108 bacteria per lane were electrophoresed under reducing conditions with the buffer system of Laemmli (28) -Tween) and then incubated for 1.5 h at room temperature in bovine serum that was diluted in TBS-Tween. After being rinsed twice in TBSTween, the nitrocellulose was incubated in a 1:2,000 dilution of peroxidase-conjugated, affinity-purified, goat anti-bovine IgG (heavy and light chain specific; Kirkegaard and Perry) for 1.5 h at room temperature. In some cases the goat anti-bovine IgG conjugate was replaced with protein Aperoxidase (Kirkegaard and Perry) or monoclonal mouse anti-bovine IgGl and IgG2, followed by anti-mouse IgG peroxidase, as described above for the ELISA. Blots were rinsed in distilled water and washed twice in TBS. Immunoreactivity was visualized with 60 mg of 4-chloro-1-naphthol (Bio-Rad) in 20 ml of methanol, which was added to 100 ml of TBS with 0.018% hydrogen peroxide (added immediately before use). The reaction was allowed to proceed for 5 min before the blots were rinsed repeatedly in distilled water and dried.
Monoclonal and then killed with an intravenous overdose of sodium pentobarbitone (Veterinary Laboratories, Inc., Lenexa, Kans.). Swabs were collected from caudal lung lobes and the right cranial lobe and were submitted to the Washington Animal Disease Diagnostic Laboratory for routine bacteriologic culture, including mycoplasmal culture and viral culture for bovine respiratory viruses (parainfluenza type 3 virus, infectious bovine rhinotracheitis virus, and bovine virus diarrhea virus). The lungs were perfused with normal saline via the pulmonary artery before swabs of caudal lungs were taken for bacteriologic and virologic culture. Lungs were fixed by vascular perfusion with 4% formaldehyde-1% glutaraldehyde, as described previously (16) . The fixed lungs were sectioned serially every 3 mm starting at the caudal extremity of each caudal lung. After postfixation overnight in 4% formaldehyde-1% glutaraldehyde, the lesions were delineated grossly and areas of pneumonic lung were determined by using a computerized image analysis system (Bioquant IV: R and M Biometrics, Nashville, Tenn.) as described previously (13, 16) . The paired student t test (one-tailed) was used to determine whether lungs inoculated with H. somnus incubated with each postimmunization immunoglobulin fraction had less pneumonia than lungs inoculated with H. somnus incubated with the homologous preimmunization immunoglobulin fraction. Histologic sections were prepared from all grades of gross lesions and were stained with hematoxylin-eosin.
RESULTS
Antisera against the 78-and 40-kDa OMPs. The specificity of antisera against the 78-and 40-kDa OMPs is demonstrated in Western blots (Fig. 1) . Preimmunization serum (1:1,500) against the 78-or 40-kDa OMPs did not contain detectable antibody to H. somnus, while postimmunization sera (1: 1,500) contained reactivity only to the 78-or the 40-kDa OMP. ELISA with whole H. somnus cells used as the antigen showed that antiserum against the 78-kDa OMP had a 16-fold increase in IgGl titer compared with the preimmunization serum, but there was essentially no change in the IgM titer and there was no detectable IgG2 titer (Table 1) . In contrast, although antiserum against the 40-kDa OMP had a moderate increase in IgGl titer (6-fold) and essentially no change in IgM titer, there was a substantial increase in the IgG2 titer (45-fold) compared with the respective preimmunization serum from the same calf (Table 1 ). In Western blots of solubilized whole H. somnus antigens, both IgGl and IgG2 antibodies were shown to react with the 40-kDa OMP whether the IgG2 was detected by monoclonal antiIgG2 or protein A peroxidase (Fig. 2) . The latter has been shown to react with bovine IgG2 (30; R. P. Gogolewski, unpublished data). The concentration of antibody against the 78-and 40-kDa OMPs generally resulted in two-to threefold increases of each immunoglobulin isotype tested, as determined by ELISA of H. somnus (Table 1 ). In parallel Western blot and densitometry studies (Fig. 3 ) of unconcentrated and concentrated antibodies against the 78-and 40-kDa OMPs, reactivity was detected with concentrated antibody at one threefold dilution higher than that detected with the homologous unconcentrated serum.
Antisera against both the 78-and 40-kDa OMPs contained antibody against H. somnus LPS, as determined by ELISA by using purified H. somnus LPS as the antigen (Table 2) . There was not more than a twofold increase in anti-LPS titer with any of the isotypes tested (IgGl, IgG2, and IgM) in the antiserum against the 78-kDa OMP or with IgM antibodies in the antiserum against the 40-kDa OMP. This was considered to be within the error limits of the assay. In the antiserum against the 40-kDa OMP, IgGl and IgG2 anti-LPS titers increased about 12-and 4-fold, respectively (Table 2) . Antisera against the 78-or 40-kDa OMP at the lowest dilution tested (1:1,500) failed to react with LPS in Western blots of whole cells (Fig. 1) or purified LPS (data not shown). Convalescent-phase serum, however, did react with purified LPS in Western blots at dilutions to 1:2,000, as we have shown previously (15) . In order to determine the reason for the increase in antibody against H. somnus LPS in the antiserum against the 40-kDa OMP, we addressed the possibility that the gel-purified 40-kDa OMP used for immunizations may have been contaminated with LPS. Western blots of H. somnus outer membranes (15) were reacted with monoclonal antibodies against H. somnus LPS. Although these monoclonal antibodies reacted with LPS (at a relative molecular mass of 10 to 14 kDa) in blots of outer membranes (Fig. 4) , there was no reactivity detected at the level of the 40-kDa OMP, which corresponded to the band cut from the SDS-polyacrylamide gel of outer membranes for emulsification with adjuvant for immunization. Surface reactivity of antisera against the 78-and 40-kDa OMPs. In order to determine the surface reactivity of antibodies in the pre-and postimmunization antisera, antisera against the 78-and 40-kDa OMPs were adsorbed with live, log-phase H. somnus. Adsorptions were done for 1 h at 4°C in order to ensure that the bacteria remained alive during the procedure. Surface-reactive antibodies were eluted from the bacterial surface and are referred to as pre-and postimmunization eluates. In Western blots, postimmunization 78-and 40-kDa eluates reacted intensely with the 78-and 40-kDa OMPs, respectively, while the preimmunization eluates failed to react (Fig. 5) . The reactivity observed with pre-and postimmunization eluates was almost identical to that obAla, 3 served with the corresponding homologous antisera. Additional bands with faint reactivities were detected in the 78-kDa pre-and postimmunization eluates but were not detected in blots when the homologous sera were used (1: 1,500). These additional bands stained faintly in blots of both pre-and postimmunization eluates, and therefore, they appeared to be due to nonspecific reactivity. No bands were apparent at relative molecular masses between 10 and 14 kDa, which would be characteristic of H. somnus LPS (Fig.  5) .
Passive protection. The rationale for conducting passive protection experiments with an inoculum dose of 107 CFU of H. somnus and bronchoscopic techniques to inoculate each caudal lung lobe in an animal separately was based on results of our prior studies, in which we showed that an inoculum dose of 107 CFU of H. somnus 2336 reliably produces a focally extensive, well-demarcated pneumonia in calves (15, 16) . The bronchoscopic technique permits evaluation of the protective capacity of pre-and postimmunization sera in the same animal, thereby overcoming problems of variation between animals and resulting in the use of a minimal number of experimental animals. In preliminary experiments neither unconcentrated antiserum sample against the 78-or 40-kDa OMP protected passively against H. somnus pneumonia; therefore, we decided to fractionate and concentrate immunoglobulin from each of the antisera prior to use in the experiments reported here.
In experiments with concentrated immunoglobulin, bacterial counts of each inoculum sample were essentially the same before and after incubation with pre-or postimmunization immunoglobulins, verifying that bacterial agglutination was not a factor. After inoculation all calves were mildly or moderately depressed, coughed occasionally, and were febrile (mean temperatures increased from 39,2 + 0.3°C to 40.2 + 0.5°C). At necropsy 24 h after inoculation, H. somnus was recovered from left and right lung lobes and anterior bronchi of all calves. No viruses or other bacterial pathogens, including mycoplasmas, were isolated. The volume of pneumonic lung was significantly (P < 0.025) greater in lungs inoculated with bacteria incubated with preimmunization immunoglobulin against the 40-kDa OMP compared with lungs inoculated with bacteria incubated with postimmunization antibody (Table 3) . Conversely, although there appeared to be more pneumonia in the presence of antibody to the 78-kDa OMP, no significant difference (P > 0.05) in the volume of pneumonia was detected when lungs inoculated with bacteria incubated with pre-or postimmunization immunoglobulin against the 78-kDa OMP were compared (Table 3) . Although quantitative differences were identified in volumes of pneumonic lung in sides inoculated with preor postimmunization antibody against the 40-kDa OMP, gross lesions were qualitatively similar (Fig. 6) necrotizing bronchiolitis, lobular necrosis, neutrophilic to fibrinoid vasculitis sometimes associated with thrombosis, degeneration of alveolar macrophages, and dilation and thrombosis of lymphatic tissues were present in protected and unprotected caudal lung lobes of all calves 24 h postinoculation. The cranial lung lobes (which were inoculated with preimmune serum but not with bacteria) were either normal or contained occasional small focal areas of neutrophilic bronchiolitis and alveolitis. DISCUSSION In this study we showed that bovine antibody against the 40-kDa OMP protected, but antibody against the 78-kDa OMP did not protect, calves against H. somnus pneumonia. Although the antisera prepared against the 78-and 40-kDa OMPs were essentially monospecific, anti-LPS antibody was present in both sera. The increase in anti-LPS activity was twofold or less for all three isotypes of anti-78-kDa antibody. Since the preimmunization serum did not protect against infection and the difference in titer between pre-and postimmunization sera was within the error of the tests, we concluded that this anti-LPS antibody could be discounted. In the antiserum against the 40-kDa OMP, there was no (17) and Salmonella typhimurium (40) . The 39-kDa OMP of H. influenzae type b, which was purified by differential solubility in detergents, was found to contain LPS and to elicit anti-LPS antibody following immunization of rats (17) . In studies with purified porins from S. typhimurium, protection observed in a mouse model was originally reported to be due to anti-porin antibodies (27) , but was later shown to be due to antibodies directed against LPS contaminants of the porin protein preparation (40) .
Results of the latter study are different from those of our study, in that Salmonella LPS has long 0 side chains (42) , making Salmonella LPS much more immunogenic than H. somnus LPS. The major reason for increasing anti-LPS titers in the calf immunized with the 40-kDa OMP may be the age of the calf, since young calves have very low natural antibody titers (9) but older cattle have cross-reacting anti-LPS antibodies (12) . Postimmunization serum was collected at 19 and 33 weeks of age for the 78-and the 40-kDa OMPs, respectively. Therefore, the small increase in anti-LPS activity in the antiserum against the 40-kDa OMP was probably due to natural antibodies that increased with age rather than to LPS contamination of the 40-kDa OMP. The low levels of anti-LPS antibody, however, may have contributed to the protection observed with the antiserum against the 40-kDa OMP.
The major reactivity of the two antisera was demonstrated by (i) immunoblots showing that reactivity to the 40-or 78-kDa OMP was present in postimmunization but not preimmunization serum and (ii) immunoblots with eluates from live bacterial adsorption studies of each antiserum, demonstrating that essentially only antibody to the 40-or 78-kDa OMP is reactive with the surface of H. somnus in each antiserum. Furthermore, the experimental protocol permitted the respective preimmunization sera to be used as controls in each experimental animal, thereby controlling for the effects of small amounts of preexisting cross-reactive or natural antibody to H. somnus. To explain the protection with the antiserum to the 40-kDa OMP but not the antiserum to the 78-kDa OMP, it is necessary to address several important characteristics of the antisera, including (i) isotype distribution, (ii)antibody specificity, and (iii) antibody titer. These two antisera were markedly different in their isotype distributions of antibodies against H. somnus, in that the protective immunoglobulin fraction contained IgGl, IgG2, and IgM antibodies, while the nonprotective immunoglobulin fraction against the 78-kDa OMP contained only IgGl and IgM but no detectable IgG2 against H. somnus, as determined by ELISA. Pre-and postimmunization immunoglobulin fractions contained similar IgM titers against H. somnus, but the preimmunization immunoglobulin fraction did not afford protection in either case, indicating that IgM antibodies against the OMPs do not play a role in protection. Since both protective and nonprotective immunoglobulin fractions had IgGl antibodies to the selected OMPs, whereas only the protective antiserum had IgG2 antibodies, it appears that IgG2 may be important in providing protection against H. somnus pneumonia. The fact that the IgG2 antibodies against the 40-kDa OMP reacted only with the 40-kDa antigen in Western blots strengthens the hypothesis that IgG2 antibodies to OMP may play a significant role. Several lines of evidence indicate that IgG2 is important in offering protection against several bacterial diseases in cattle. Red Danish milk cattle that are deficient in IgG2 have reduced resistance to pyogenic infections (37) . Of the IgG2-deficient animals, 36% (8 of 22) had bronchopneumonia (37) .
Furthermore, protection against staphylococcal mastitis in cattle and sheep is principally correlated with levels of anti-staphylococcal IgG2 in serum (45, 46) . Receptors on neutrophils for the Fc region of IgG2 transport cytophilic IgG2 (4) into the mammary secretion, where the opsonizing activity of cytophilic IgG2 of appropriate specificity can increase the clearance of Staphylococcus aureus. Similarly, ovine IgG2 specific for the surface of Bacteroides nodosus is a strong opsonin for neutrophils and therefore is thought to be important in protection (14) . Since neutrophilic infiltrates characterize acute H. somnus pneumonia (16) , similar IgG2-mediated mechanisms may be important in protecting calves against H. somnus pneumonia. Recently, Czuprynski and Hamilton (11) have shown that bovine peripheral blood neutrophils ingest but do not kill H. somnus in vitro. However, the H. somnus antiserum used in those experiments was prepared by subcutaneous injection of Formalinkilled bacteria, and there was no information on the distribution of immunoglobulin isotypes in the antiserum. It may be that Formalin-killed H. somnus did not stimulate IgG2 antibodies, since vaccination of sheep and cattle with killed S. aureus has been shown to produce predominantly an IgGl response, whereas immunization with live S. aureus stimulates a substantial IgG2 response (25, 45, 46) . We have shown that convalescent-phase serum from calves with H. somnus pneumonia is passively protective in vivo (15) . This protective convalescent-phase serum had both IgGl and IgG2 antibodies against both the 78-and 40-kDa antigens (unpublished data). Hence, it is possible that cytophilic IgG2 with an appropriate specificity may be important in the opsonization and killing of H. somnus by bovine neutrophils in the lungs. Earlier, Corbeil et al. (9) have shown that immunoglobulin concentrations in serum and nasal secretions of young calves correlated inversely with the occurrence of pneumonia. In that study, the peak onset of pneumonia occurred when the IgGl, IgG2, and IgA concentrations in the sera of calves were lowest; and as IgG2 concentrations increased, fewer calves developed pneumonia, suggesting a role for IgG2 in protection against pneumonia. It has also been shown that bovine IgG2 is more opsonic than IgGl (33) . Hence, if opsonization is important in the clearance of H. somnus, then specific IgG2 against H. somnus is likely to be protective. In our studies of experimental H. somnus abortion in cattle, the greatest and most persistent specific serum antibody response was within the IgG2 subclass; and prechallenge H. somnus IgG2 titers were lower in animals that aborted than in animals that calved normally, suggesting that IgG2 antibodies against H. somnus may limit hematogenous dissemination of H. somnus (48) . Therefore, many lines of evidence indicate that IgG2 plays a potentially important role in offering protection against bacterial diseases in cattle in general and against H. somnus in particular. The lack of protection offered by the antibodies against the 78-kDa OMP may have been due to its lack of specific IgG2 antibody. Studies are in progress to elicit an IgG2 response against the purified 78-kDa OMP, since we know that infected cattle produce IgG2 antibodies against the 78-kDa OMP (unpublished data). Then, we will be able to determine whether antibodies of this isotype, which are specific for the 78-kDa antigen, are protective. The protection demonstrated with the antibodies against the 40-kDa OMP may be due, in part at least, to the presence of IgG2 antibodies that are specific for the 40-kDa OMP.
The importance of antibody specificity in protection also has been highlighted by numerous studies involving a diverse range of bacteria, which indicate differences among OMPs in their ability to induce protective immunity. For example, polyclonal antibodies to the P5 OMP of H. influenzae type b (36) and monoclonal antibody to the porin OMP of Pseudomonas aeruginosa (38) are not protective in respective animal models of disease, while monoclonal antibody to the 98-kDa OMP of H. influenzae type b (26) and polyclonal antibodies to P6 (36) 
